Balance Sheet for Ra Pharmaceuticals Inc. (RARX)

$ N/A N/A (N/A) Volume: 0 N/A
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 264,992 209,822 70,381 117,812 19,386
Restrictable Cash - - - - -
Marketable Securities - - - - -
Accounts Receivable - - - 7 6
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables - - - 7 6
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 9,702 2,585 2,496 1,690 800
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 274,694 212,407 72,877 119,502 20,186
Land and Improvements - - - - -
Buildings and Improvement 3,744 3,755 3,753 3,732 793
Machinery, Furniture and Equipment 7,075 6,592 5,514 4,007 3,074
Construction in Progress 490 - 336 - 535
Fixed Assets, Other 3,109 - (336) - -
Fixed Assets, Total 14,418 10,347 9,267 7,739 4,402
Gross Fixed Assets 14,418 10,347 9,267 7,739 4,402
Accumulated Depreciation (6,577) (5,182) (3,661) (2,202) (2,259)
Net Fixed Assets 7,841 5,165 5,606 5,537 2,143
Intangibles - 131 197 262 327
Cost in Excess - 183 183 183 183
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 1,617 1,648 1,334 1,334 1,503
Total Non-Current Assets 9,458 6,813 7,320 7,316 4,156
Total Assets 284,152 219,220 80,197 126,818 24,342
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 1,817 3,245 4,348 3,252 1,319
Short Term Debt 1,584 - - - -
Notes Payable - - - - -
Accrued Expenses 15,178 6,477 3,937 3,182 1,274
Accrued Liabilities 15,178 6,477 3,937 3,182 1,274
Deferred Revenues - - - - 1,621
Current Deferred Income Taxes - - - - -
Other Current Liabilities - 479 329 303 2,724
Total Current Liabilities 18,579 10,201 8,614 6,737 6,938
Long Term Debt 3,438 - - - -
Deferred Income Tax 21 21 40 59 77
Other Non-Current Liabilities - 1,880 2,359 2,800 851
Minority Interest - - - - -
Capital Lease Obligations 3,438 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - 53,675
Total Non-Current Liabilities 3,459 1,901 2,399 2,859 54,603
Total Liabilities 22,038 12,102 11,013 9,596 61,541
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 262,114 207,118 69,184 117,222 (37,199)
Common Par 47 42 23 23 1
Additional Paid in Capital 552,912 395,233 192,375 185,963 2,700
Cumulative Translation Adjustments - - - - -
Retained Earnings (290,845) (188,157) (123,214) (68,764) (39,900)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 262,114 207,118 69,184 117,222 (37,199)
Total Equity 262,114 207,118 69,184 117,222 (37,199)
Total Liabilities & Shareholder's Equity 284,152 219,220 80,197 126,818 24,342
Cash Flow (102,688) (64,943) (54,439) (28,864) (13,943)
Working Capital 256,115 202,206 64,263 112,765 13,248
Free Cash Flow (88,226) (55,980) (48,191) (26,948) (12,348)
Invested Capital 262,114 207,118 69,184 117,222 (37,199)
Shares Outstanding - Common Class Only 47,222 42,072 22,626 22,546 -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 47,222 42,072 22,626 22,546 21,489
Total Common Shares Outstanding 47,222 42,072 22,626 22,546 -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 44,363 31,542 22,591 4,135 7,721
Diluted Weighted Shares Outstanding 44,363 31,542 22,591 4,135 7,721